Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Gross Profit (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Gross Profit over the past 16 years, most recently at $14.0 million for Q2 2025.

  • Quarterly results put Gross Profit at $14.0 million for Q2 2025, down 19.05% from a year ago — trailing twelve months through May 2025 was $40.3 million (down 3.71% YoY), and the annual figure for FY2025 was $40.3 million, down 3.71%.
  • Gross Profit for Q2 2025 was $14.0 million at Lifecore Biomedical, Inc. \De\, up from $9.8 million in the prior quarter.
  • Over the last five years, Gross Profit for LFCR hit a ceiling of $17.3 million in Q2 2024 and a floor of $2.7 million in Q3 2023.
  • Median Gross Profit over the past 5 years was $10.2 million (2022), compared with a mean of $9.7 million.
  • Biggest five-year swings in Gross Profit: plummeted 54.37% in 2023 and later soared 122.03% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Gross Profit stood at $11.5 million in 2021, then plummeted by 50.44% to $5.7 million in 2022, then soared by 75.33% to $10.0 million in 2023, then rose by 11.32% to $11.1 million in 2024, then increased by 26.15% to $14.0 million in 2025.
  • The last three reported values for Gross Profit were $14.0 million (Q2 2025), $9.8 million (Q1 2025), and $11.1 million (Q4 2024) per Business Quant data.